679 results on '"Budde, Ulrich"'
Search Results
52. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD
53. Platelet Dysfunction and a High Bone Mass Phenotype in a Murine Model of Platelet-Type von Willebrand Disease
54. Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis
55. Inherited Thrombotic Thrombocytopenic Purpura in Children
56. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)
57. Laboratory Diagnosis of von Willebrand Disease: The Phenotype
58. Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis
59. Current Diagnostic and Therapeutic Approaches to Patients with Acquired von Willebrand Syndrome: A 2013 Update
60. Generation of Inhibitory Autoantibodies to ADAMTS13 in Coronavirus Disease 2019
61. Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura
62. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019
63. The Unrecognized von Willebrand Disease: A Frequent Cause of Bleeding Complications
64. COVID-19 is associated with relative ADAMTS13 deficiency and VWF multimer formation resembling TTP
65. Upshaw-Schulman syndrome-associated ADAMTS13 variants possess proteolytic activity at the surface of endothelial cells and in simulated circulation
66. The impact of bleeding history, von Willebrand factor and PFA–100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD
67. Phenotypic and genotypic diagnosis of von Willebrand disease: A 2004 update
68. Intravenous DDAVP and Factor VIII-von Willebrand Factor Concentrate for the Treatment and Prophylaxis of Bleedings in Patients With von Willebrand Disease Type 1, 2 and 3
69. Identification of a candidate missense mutation in a family with von Willebrand disease type IIC
70. Comparative Analysis and Classification of von Willebrand Factor/Factor VIII Concentrates: Impact on Treatment of Patients with von Willebrand Disease
71. The Paradox of Platelet Activation and Impaired Function: Platelet-von Willebrand Factor Interactions, and the Etiology of Thrombotic and Hemorrhagic Manifestations in Essential Thrombocythemia and Polycythemia Vera
72. Immune-Mediated Etiology of Acquired von Willebrand Syndrome in Systemic Lupus Erythematosus and in Benign Monoclonal Gammopathy: Therapeutic Implications
73. Laboratory Testing for von Willebrand Disease: Contribution of Multimer Analysis to Diagnosis and Classification
74. von Willebrand Factor-Cleaving Protease (ADAMTS13) in the Course of Stem Cell Transplantation
75. Genetic heterogeneity of severe von Willebrand disease type III in the German population
76. Characterization, Classification, and Treatment of von Willebrand Diseases: A Critical Appraisal of the Literature and Personal Experiences
77. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS)
78. Severe ADAMTS-13 deficiency in childhood
79. Prolonged inhibition of von Willebrand factor-cleaving protease after splenectomy in a 22-year-old patient with acute and plasma refractory thrombotic thrombocytopenic purpura
80. Acquired von Willebrand Syndrome: Experience from 2 Years in a Single Laboratory Compared with Data from the Literature and an International Registry
81. Laboratory Diagnosis of Congenital von Willebrand Disease
82. von Willebrand factor cleaving protease and ADAMTS13mutations in childhood TTP
83. Risk factors for bleeding from gastrointestinal angiodysplasia: a case-control study in patients with bleeding and non-bleeding angiodysplasia
84. Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myeloma
85. Molecular Etiology and Laboratory Phenotypes of Recessive Von Willebrand Disease 2N Due to Mutations in the D’D3 Factor VIII-Binding Domain of the Von Willebrand Factor Gene: A Critical Appraisal of the Literature and Personal Experiences
86. Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease
87. ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysis
88. Alteration in GPIIb/IIIa Binding of VWD-Associated von Willebrand Factor Variants with C-Terminal Missense Mutations
89. Therapeutic plasma exchange and plasma infusion in thrombotic microvascular syndromes
90. The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count
91. Multifaceted pathomolecular mechanism of a VWFlarge deletion involved in the pathogenesis of severe VWD
92. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management
93. A molecular approach to the classification of von Willebrand disease
94. Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease
95. von Willebrand Factor Mutation Enhancing Interaction With Platelets in Patients With Normal Multimeric Structure
96. Advancing multimer analysis of von Willebrand factor by single-molecule AFM imaging
97. The von Willebrand factor ratio and perioperative bleeding in patients with aortic valve stenosis
98. Superiority of the Rapid Von Willebrand Factor (VWF) VWF:GPIbR and VWF:GPIbM Assays in Type 2A, 2B and 2M Von Willebrand Disease
99. Moeglichkeiten individualisierter Arbeit mit Hilfe des Overhead-Projektors (Possibilities for Individualized Work with the Aid of the Overhead Projector)
100. Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.